Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Lennox, Jeffrey L, Prof, DeJesus, Edwin, MD, Lazzarin, Adriano, Prof, Pollard, Richard B, Prof, Madruga, Jose Valdez Ramalho, MD, Berger, Daniel S, MD, Zhao, Jing, PhD, Xu, Xia, PhD, Williams-Diaz, Angela, BS, Rodgers, Anthony J, MS, Barnard, Richard JO, PhD, Miller, Michael D, PhD, DiNubile, Mark J, MD, Nguyen, Bach-Yen, MD, Leavitt, Randi, MD, Sklar, Peter, Dr
Published in The Lancet (British edition) (05.09.2009)
Published in The Lancet (British edition) (05.09.2009)
Get full text
Journal Article
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial
Eron, Joseph J, Prof, Rockstroh, Jürgen K, MD, Reynes, Jacques, Prof, Andrade-Villanueva, Jaime, MD, Ramalho-Madruga, Jose Valdez, MD, Bekker, Linda-Gail, MD, Young, Benjamin, MD, Katlama, Christine, MD, Gatell-Artigas, Jose Maria, MD, Arribas, Jose R, MD, Nelson, Mark, MD, Campbell, Havilland, BS, Zhao, Jing, PhD, Rodgers, Anthony J, MS, Rizk, Matthew L, PhD, Wenning, Larissa, PhD, Miller, Michael D, PhD, Hazuda, Daria, PhD, DiNubile, Mark J, MD, Leavitt, Randi, MD, Isaacs, Robin, MD, Robertson, Michael N, MD, Sklar, Peter, MD, Nguyen, Bach-Yen, Dr
Published in The Lancet infectious diseases (01.12.2011)
Published in The Lancet infectious diseases (01.12.2011)
Get full text
Journal Article